NEW YORK (GenomeWeb) – Danaher today reported a 10 percent year-over-year increase in its third quarter revenues, boosted by a 20 percent increase in sales in its diagnostics segment.

For the three months ending Sept. 29, total sales rose to $4.53 billion, compared to $4.13 in the year-ago period, and beating the consensus Wall Street estimate of $4.47 billion.